This federal contract award is for a Delivery Order under the National Institute of Allergy and Infectious Diseases (NIAID) Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The $1,513,255.77 cost-plus-fixed-fee contract was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute, to provide a non-human primate model for testing the immunogenicity and...
This federal contract award is a delivery order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery, indefinite-quantity (IDIQ) contract. The prime contractor is Battelle Memorial Institute, a nonprofit research and development organization. The $5,106,315.95 delivery order provides base task order funding for Task B02, supporting the National Institute of Allergy and Infectious Diseases' (NIAID) pre-clinical models of infectious diseases program. No...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2,000 firm fixed price delivery order against an unspecified contract vehicle to Lovelace Biomedical Research Institute. The delivery order is for comprehensive and rapid response services to support NIAID's research programs over a one year period from September 2021 through August 2022. The place of performance will be in Bethesda, Maryland. No set aside designation or subcontractors were...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $716,374 delivery order contract to Lovelace Biomedical Research Institute. Under the terms of the firm fixed price contract, Lovelace Biomedical Research Institute will conduct a Good Laboratory Practice repeat dose toxicology study for BPL-24910 in support of the Comprehensive and Rapid Response for NIAID Research Programs major program code. Performance...
This is a task order award under a federal contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The $2,910,502 cost-plus-fixed-fee contract was awarded to Leidos, Inc., a global technology and engineering company, to provide preclinical services for the development of biopharmaceutical products targeting infectious diseases. The contract has a completion date of September 19, 2021 and was awarded on...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $486,301.00 cost-plus-fixed-fee delivery order contract to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization. Under this contract, the Lovelace Biomedical Research Institute will perform the transfer, validation, and qualification of bioanalytical methods for the detection of cabotegravir and levonorgestrel in rat and nonhuman primate plasma. This work is being conducted...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $6,452,710.88 delivery order against the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ to the American Foundation For Biological Research, doing business as Biomedical Research Institute, for maintenance, development and production of schistosomiasis parasites, and reagents with a completion date of July 7, 2023. The contract has no...
This is a new task order award valued at $7,029,612.00 issued under the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery contract. The prime contractor is Trustees of Boston University, doing business as Boston University Medical Campus, which is a leading private research institution with expertise in areas such as neuroscience, biomedical engineering, infectious disease, and public health. The task order is...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $332,878 delivery order to Pharmacology Discovery Services Taiwan, LTD under the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. This cost-plus-award-fee contract will provide pre-clinical models of infectious diseases to support research efforts at NIAID through September 1, 2021. As part of its mission to conduct and support research on infectious, immunologic, and...
This is a cost-no-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to the American Foundation For Biological Research (doing business as Biomedical Research Institute), a non-profit organization. The $523,459 contract is for the maintenance, development, and production of schistosomiasis parasites, reagents, and assays, which supports the NIAID's research on...
This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization. The task order, titled "PRE-CLINICAL MODELS OF INFECTIOUS DISEASES TASK ORDER B07", is part of NIAID's Preclinical Models of Infectious Diseases contract vehicle, which provides preclinical research services to support the development of treatments and cures for infectious diseases. This $7,956,047.62 cost-plus-fixed-fee task order has a performance period running through July 13, 2024. The contract does not have a set-aside designation. As a subsidiary of Lovelace Biomedical Research Institute, LBERI leverages over 70 years of expertise in areas like inhalation toxicology, infectious disease modeling, and medical countermeasure testing to support federal agencies such as NIAID, the Biomedical Advanced Research and Development Authority (BARDA), and the National Center for Advancing Translational Sciences (NCATS).